145 related articles for article (PubMed ID: 34621605)
1. COVID-19 reinfection in a patient with a serious mental illness within a long-term inpatient psychiatric care hospital.
Englett B; Magdalany A; Gordon TL; Holladay K
Ment Health Clin; 2021 Sep; 11(5):292-296. PubMed ID: 34621605
[TBL] [Abstract][Full Text] [Related]
2. A Patient with Asymptomatic SARS-CoV-2 Infection Who Presented 86 Days Later with COVID-19 Pneumonia Possibly Due to Reinfection with SARS-CoV-2.
Sharma R; Sardar S; Mohammad Arshad A; Ata F; Zara S; Munir W
Am J Case Rep; 2020 Dec; 21():e927154. PubMed ID: 33257644
[TBL] [Abstract][Full Text] [Related]
3. Severe acute respiratory syndrome coronavirus 2 reinfection in a coronavirus disease 2019 recovered young adult: a case report.
Awada H; Nassereldine H; Hajj Ali A
J Med Case Rep; 2021 Jul; 15(1):382. PubMed ID: 34271967
[TBL] [Abstract][Full Text] [Related]
4. Recovery scenario and immunity in COVID-19 disease: A new strategy to predict the potential of reinfection.
Khoshkam Z; Aftabi Y; Stenvinkel P; Paige Lawrence B; Rezaei MH; Ichihara G; Fereidouni S
J Adv Res; 2021 Jul; 31():49-60. PubMed ID: 33520309
[TBL] [Abstract][Full Text] [Related]
5. Late reinfection with a different severe acute respiratory syndrome coronavirus-2 clade in a patient with refractory arterial hypertension: a case report.
García-Abellán J; Galiana A; Fernández-González M; Gonzalo-Jiménez N; Ruiz-García M; Botella A; Sanchis J; Mascarell P; Falcón S; Masiá M; Gutiérrez F
J Med Case Rep; 2021 Sep; 15(1):454. PubMed ID: 34488872
[TBL] [Abstract][Full Text] [Related]
6. Association Between the Use of Psychotropic Medications and the Risk of COVID-19 Infection Among Long-term Inpatients With Serious Mental Illness in a New York State-wide Psychiatric Hospital System.
Nemani K; Williams SZ; Olfson M; Leckman-Westin E; Finnerty M; Kammer J; Smith TE; Silverman DJ; Lindenmayer JP; Capichioni G; Clelland J; Goff DC
JAMA Netw Open; 2022 May; 5(5):e2210743. PubMed ID: 35522282
[TBL] [Abstract][Full Text] [Related]
7. SARS-CoV-2 incidence, transmission and reinfection in a rural and an urban setting: results of the PHIRST-C cohort study, South Africa, 2020-2021.
Cohen C; Kleynhans J; von Gottberg A; McMorrow ML; Wolter N; Bhiman JN; Moyes J; du Plessis M; Carrim M; Buys A; Martinson NA; Kahn K; Tollman S; Lebina L; Wafawanaka F; du Toit J; Xavier Gómez-Olivé F; Dawood FS; Mkhencele T; Sun K; Viboud C; ; Tempia S
medRxiv; 2021 Dec; ():. PubMed ID: 34909794
[TBL] [Abstract][Full Text] [Related]
8. Severe reinfection with severe acute respiratory syndrome coronavirus 2 in a nursing home resident: a case report.
Bader N; Khattab M; Farah F
J Med Case Rep; 2021 Jul; 15(1):392. PubMed ID: 34284812
[TBL] [Abstract][Full Text] [Related]
9. Severe, Symptomatic Reinfection in a Patient with COVID-19.
Selvaraj V; Herman K; Dapaah-Afriyie K
R I Med J (2013); 2020 Nov; 103(10):24-26. PubMed ID: 33172223
[TBL] [Abstract][Full Text] [Related]
10. A case of COVID-19 reinfection in a hemodialysis patient: the role of antibody in SARS-CoV-2 infection.
Beppu H; Ogawa T; Ishikane M; Kawanishi T; Fukuda T; Sato L; Matsunaga A; Maeda K; Katagiri D; Ishizaka Y; Mitsuya H; Ohmagari N; Yasui F; Kohara M; Kikuchi K; Wakai S
CEN Case Rep; 2022 Nov; 11(4):422-427. PubMed ID: 35266095
[TBL] [Abstract][Full Text] [Related]
11. Predictors of severe symptomatic laboratory-confirmed SARS-CoV-2 reinfection.
Murillo-Zamora E; Mendoza-Cano O; Delgado-Enciso I; Hernandez-Suarez CM
Public Health; 2021 Apr; 193():113-115. PubMed ID: 33774512
[TBL] [Abstract][Full Text] [Related]
12. Coronavirus Occurrence in the Household Influenza Vaccine Evaluation (HIVE) Cohort of Michigan Households: Reinfection Frequency and Serologic Responses to Seasonal and Severe Acute Respiratory Syndrome Coronaviruses.
Petrie JG; Bazzi LA; McDermott AB; Follmann D; Esposito D; Hatcher C; Mateja A; Narpala SR; O'Connell SE; Martin ET; Monto AS
J Infect Dis; 2021 Jul; 224(1):49-59. PubMed ID: 33755731
[TBL] [Abstract][Full Text] [Related]
13. Exploring the Impact of COVID-19 Vaccination on Patients Taking Clozapine.
Demler TL; O'Donnell C
Innov Clin Neurosci; 2023; 20(1-3):32-38. PubMed ID: 37122573
[TBL] [Abstract][Full Text] [Related]
14. Effectiveness Associated With Vaccination After COVID-19 Recovery in Preventing Reinfection.
Lewis N; Chambers LC; Chu HT; Fortnam T; De Vito R; Gargano LM; Chan PA; McDonald J; Hogan JW
JAMA Netw Open; 2022 Jul; 5(7):e2223917. PubMed ID: 35895058
[TBL] [Abstract][Full Text] [Related]
15. Re-Positive SARS-CoV-2 With Respiratory Failure and Cerebrovascular Accident: Is This a Reinfection?
Baiswar S; Mittal R; Tiwary T; Jinnur P
Cureus; 2021 Jun; 13(6):e15825. PubMed ID: 34306889
[TBL] [Abstract][Full Text] [Related]
16. Clinical and Laboratory Findings in Patients With Potential Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Reinfection, May-July 2020.
Lee JT; Hesse EM; Paulin HN; Datta D; Katz LS; Talwar A; Chang G; Galang RR; Harcourt JL; Tamin A; Thornburg NJ; Wong KK; Stevens V; Kim K; Tong S; Zhou B; Queen K; Drobeniuc J; Folster JM; Sexton DJ; Ramachandran S; Browne H; Iskander J; Mitruka K
Clin Infect Dis; 2021 Dec; 73(12):2217-2225. PubMed ID: 33598716
[TBL] [Abstract][Full Text] [Related]
17. A new positive SARS-CoV-2 test months after severe COVID-19 illness: reinfection or intermittent viral shedding?
Tuan J; Spichler-Moffarah A; Ogbuagu O
BMJ Case Rep; 2021 Feb; 14(2):. PubMed ID: 33542020
[TBL] [Abstract][Full Text] [Related]
18. Possible COVID-19 reinfection case in Duhok City, Kurdistan: A case report.
Hussein NR; Musa DH; Saleem ZSM; Naqid IA; Ibrahim N
J Family Med Prim Care; 2021 May; 10(5):2035-2037. PubMed ID: 34195145
[TBL] [Abstract][Full Text] [Related]
19. Evidence of Severe Acute Respiratory Syndrome Coronavirus 2 Reinfection After Recovery from Mild Coronavirus Disease 2019.
Lee JS; Kim SY; Kim TS; Hong KH; Ryoo NH; Lee J; Park JH; Cho SI; Kim MJ; Kim YG; Kim B; Shin HS; Oh HS; Seo MS; Gwon TR; Kim Y; Park JS; Chin BS; Park WB; Park SS; Seong MW
Clin Infect Dis; 2021 Nov; 73(9):e3002-e3008. PubMed ID: 33219681
[TBL] [Abstract][Full Text] [Related]
20. Robust humoral and cellular immune responses and low risk for reinfection at least 8 months following asymptomatic to mild COVID-19.
Havervall S; Ng H; Jernbom Falk A; Greilert-Norin N; Månberg A; Marking U; Laurén I; Gabrielsson L; Salomonsson AC; Aguilera K; Kihlgren M; Månsson M; Rosell A; Hellström C; Andersson E; Olofsson J; Skoglund L; Yousef J; Pin E; Lord M; Åberg M; Hedhammar M; Tegel H; Dönnes P; Phillipson M; Nilsson P; Klingström J; Mangsbo S; Hober S; Thålin C
J Intern Med; 2022 Jan; 291(1):72-80. PubMed ID: 34459525
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
